← All themes

Immunotherapy & Oncology

Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.

388 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
376	376 DELISTED Syros Pharmaceuticals, Inc. Common Stock SYRS	–	–	–	–
377	TCBP 377 DELISTED TC BioPharm (Holdings) plc American Depositary Shares TCBP	–	–	–	–
378	TCON 378 DELISTED TRACON Pharmaceuticals, Inc. Common Stock TCON	–	–	–	–
379	TCRR 379 DELISTED TCR2 Therapeutics Inc. Common Stock TCRR	–	–	–	–
380	THRX 380 DELISTED Theseus Pharmaceuticals, Inc. Common Stock THRX	–	–	–	–
381	TPTX 381 DELISTED Turning Point Therapeutics, Inc. Common Stock TPTX	–	–	–	–
382	382 DELISTED Turnstone Biologics TSBX	–	–	–	–
383	383 DELISTED 2seventy bio TSVT	–	–	–	–
384	384 DELISTED VBI Vaccines, Inc. New Common Stock (Canada) VBIV	–	–	–	–
385	385 DELISTED Vaccinex, Inc. Common Stock VCNX	–	–	–	–
386	386 DELISTED Vincerx Pharma, Inc. Common Stock VINC	–	–	–	–
387	387 DELISTED Viracta Therapeutics, Inc. Common Stock VIRX	–	–	–	–
388	388 DELISTED Y-mAbs Therapeutics YMAB	–	–	–	–